000			01288cam a22003135a 4500
001			17921915
005			20160217145113.0
008			131029t2014 caua frb 001 0 eng d
020			_a9780123820303 (alk. paper)
040			_aDLC _beng _cDLC _dDLC _dEG-ScBUE _dEG-ScBUE
082	0	4	_a615.19 _bSIL _222
100	1		_aSilverman, Richard B. _939174
245	1	4	_aThe organic chemistry of drug design and drug action / _cRichard B. Silverman, Mark W. Holladay.
250			_a3rd ed.
260			_aSan Diego : _bAcademic Press / Elsevier, _cc.2014.
300			_axviii, 517 p. : _bill. ; _c29 cm.
500			_aIndex : p. 507-517.
500			_aIncludes appendix.
504			_aIncludes bibliographic references.
505	0		_aIntroduction -- Lead discovery and lead modification -- Receptors -- Enzymes -- Enzyme inhibition and inactivation -- Dna-interactive agents -- Drug resistance and drug synergism -- Drug metabolism -- Prodrugs and drug delivery systems.
650		7	_aPharmaceutical chemistry. _2BUEsh _930027
650		0	_aBioorganic chemistry. _2BUEsh
650		0	_aMolecular pharmacology. _2BUEsh
650		7	_aDrugs _xDesign. _2BUEsh _930136
651			_2BUEsh
653			_bPPhrm _cJuly2015 _cJanuary2016 _cFebruary2016
700	1		_aHolladay, Mark W.
942			_2ddc
999			_c20096 _d20068